{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:06:02Z","timestamp":1787065562810,"version":"build-2736575974"},"reference-count":98,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada (NSERC)","doi-asserted-by":"publisher","award":["RGPIN-2018-05501"],"award-info":[{"award-number":["RGPIN-2018-05501"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Global Water Futures","award":["RGPIN-2018-05501"],"award-info":[{"award-number":["RGPIN-2018-05501"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Myelodysplastic syndromes (MDS) are a rare form of early-stage blood cancer that typically leads to leukemia and other deadly complications. The typical diagnosis for MDS involves a mixture of blood tests, a bone marrow biopsy, and genetic analysis. Flow cytometry has commonly been used to analyze these types of samples, yet there still seems to be room for advancement in several areas, such as the limit of detection, turnaround time, and cost. This paper explores recent advancements in microflow cytometry technology and how it may be used to supplement conventional methods of diagnosing blood cancers, such as MDS and leukemia, through flow cytometry. Microflow cytometry, a more recent adaptation of the well-researched and conventional flow cytometry techniques, integrated with microfluidics, demonstrates significant potential in addressing many of the shortcomings flow cytometry faces when diagnosing a blood-related disease such as MDS. The benefits that this platform brings, such as portability, processing speed, and operating cost, exemplify the importance of exploring microflow cytometry as a point-of-care (POC) diagnostic device for MDS and other forms of blood cancer.<\/jats:p>","DOI":"10.3390\/cimb46080476","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:39:08Z","timestamp":1722004748000},"page":"8053-8070","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis"],"prefix":"10.3390","volume":"46","author":[{"given":"Marc","family":"Gonsalves","sequence":"first","affiliation":[{"name":"Department of Engineering Physics, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"},{"name":"Faculty of Health Sciences, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Escobar","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Diaa","family":"Altarabishi","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Qing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Engineering Physics, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"},{"name":"School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"ref_1","unstructured":"(2024, April 18). Global Cancer Burden Growing, amidst Mounting Need for Services. Available online: https:\/\/www.iarc.who.int\/news-events\/global-cancer-burden-growing-amidst-mounting-need-for-services\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-023-02327-3","article-title":"Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning","volume":"24","author":"Lemieux","year":"2023","journal-title":"Respir. Res."},{"key":"ref_3","first-page":"423","article-title":"Past, Present and Future of Flow Cytometry in Breast Cancer\u2014A Systematic Review","volume":"30","author":"Andreou","year":"2019","journal-title":"EJIFCC"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Austin Suthanthiraraj, P.P., and Graves, S.W. (2013). Fluidics. Curr. Protoc. Cytom., 65.","DOI":"10.1002\/0471142956.cy0102s65"},{"key":"ref_5","unstructured":"Shapiro, H.M. (2005). Practical Flow Cytometry, Wiley."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Watts, B.R., Guo, T., Zhang, Z., Xu, C., and Fang, Q. (2016). Optofluidic Device Based Microflow Cytometers for Particle\/Cell Detection: A Review. Micromachines, 7.","DOI":"10.3390\/mi7040070"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nri1416","article-title":"Seventeen-colour flow cytometry: Unravelling the immune system","volume":"4","author":"Perfetto","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sarhadi, V.K., and Armengol, G. (2022). Molecular Biomarkers in Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12081021"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood-2018-10-844670","article-title":"MDS overlap disorders and diagnostic boundaries","volume":"133","author":"Tanaka","year":"2019","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes: A Review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood.2023020078","article-title":"Diagnosis and classification of myelodysplastic syndromes","volume":"142","author":"Hasserjian","year":"2023","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"Alhan","year":"2009","journal-title":"Haematologica"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bento, L.C., Correia, R.P., Pitangueiras Mangueira, C.L., De Souza Barroso, R., Rocha, F.A., Bacal, N.S., and Marti, L.C. (2017). The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00270"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: Results of a European LeukemiaNET study","volume":"97","author":"Picone","year":"2012","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/ijlh.13047","article-title":"Flow cytometry \u201cOgata score\u201d for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience","volume":"41","author":"Velloso","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_16","unstructured":"Cleveland, C. (2010). The Myelodysplastic Syndromes. Current Clinical Medicine, W.B. Saunders. [2nd ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Toprak, S.K. (2022). Past, present and future in low-risk myelodysplastic syndrome. Front. Med., 9.","DOI":"10.3389\/fmed.2022.967900"},{"key":"ref_19","unstructured":"Hoffman, R., Benz, E.J., Silberstein, L.E., Heslop, H.E., Weitz, J.I., Anastasi, J., Salama, M.E., and Abutalib, S.A. (2018). Chapter 60\u2014Myelodysplastic Syndromes. Hematology, Elsevier. [7th ed.]."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00216-007-1827-5","article-title":"The good, the bad, and the tiny: A review of microflow cytometry","volume":"391","author":"Ateya","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bhattacharya, S., Agarwal, A.K., Chanda, N., Pandey, A., and Sen, A.K. (2018). The Microflow Cytometer. Environmental, Chemical and Medical Sensors, Springer.","DOI":"10.1007\/978-981-10-7751-7"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lin, S.-W., and Lin, C.-H. (2016). Chip-Based Cytometry Illuminated by a Blade-Shape Continuous Light for Multispectral Detection. Appl. Sci., 6.","DOI":"10.3390\/app6080229"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pillai, S., Kwan, J.C., Yaziji, F., Yu, H., and Tran, S.D. (2023). Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers. Cancers, 15.","DOI":"10.3390\/cancers15153894"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Emde, B., Kreher, H., B\u00e4umer, N., B\u00e4umer, S., Bouwes, D., and Tickenbrock, L. (2020). Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238942"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gonidec, M., and Puigmart\u00ed-Luis, J. (2019). Continuous- versus Segmented-Flow Microfluidic Synthesis in Materials Science. Crystals, 9.","DOI":"10.3390\/cryst9010012"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Scott, S.M., and Ali, Z. (2021). Fabrication Methods for Microfluidic Devices: An Overview. Micromachines, 12.","DOI":"10.3390\/mi12030319"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1039\/C5CS00717H","article-title":"Controlled droplet microfluidic systems for multistep chemical and biological assays","volume":"46","author":"Kaminski","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Elshoeibi, A.M., Badr, A., Elsayed, B., Metwally, O., Elshoeibi, R., Elhadary, M.R., Elshoeibi, A., Attya, M.A., Khadadah, F., and Alshurafa, A. (2024). Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State-of-the-Art and Future Prospects. Cancers, 16.","DOI":"10.3390\/cancers16010065"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.clml.2020.12.024","article-title":"Clinical Significance of Bone Marrow Blast Percentage in Patients with Myelofibrosis and the Effect of Ruxolitinib Therapy","volume":"21","author":"Masarova","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.seminhematol.2018.07.001","article-title":"The challenging task of enumerating blasts in the bone marrow","volume":"56","author":"Hodes","year":"2019","journal-title":"Semin. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Li, W. (2022). Flow Cytometry in the Diagnosis of Leukemias. Leukemia, Exon Publications.","DOI":"10.36255\/exon-publications-leukemia-flow-cytometry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"ref_35","unstructured":"Dietrich Werner, D.N., and George, D. (2024, April 20). What Are Other Cellular Populations That May Fall in the SCC vs. CD45 Dim Area but Are Not Blasts CD34 Positive. Available online: https:\/\/www.cytometry.org\/web\/q_view.php?id=355&filter=Interpretation%20and%20Clinical%20Application."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cyto.b.21333","article-title":"Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations","volume":"90","author":"Alhan","year":"2016","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.b.22044","article-title":"Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group","volume":"104","author":"Kern","year":"2023","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0972-3919.90264","article-title":"Transformation of myelodysplastic syndrome to acute myeloid leukemia: A case with whole-body 2-[F18] fluoro-2-deoxy-D-glucose positron emission tomography","volume":"26","author":"Liu","year":"2011","journal-title":"Indian J. Nucl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: A comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.31557\/APJCP.2021.22.5.1567","article-title":"Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children","volume":"22","author":"Fayed","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinbiochem.2011.08.1147","article-title":"Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia","volume":"45","author":"Ahmed","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.7314\/APJCP.2013.14.7.4295","article-title":"Clinical significance of serum p53 and epidermal growth factor receptor in patients with acute leukemia","volume":"14","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pmic.200900513","article-title":"Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessment","volume":"10","author":"Liang","year":"2010","journal-title":"Proteomics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0009-9120(93)80017-O","article-title":"Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia","volume":"26","author":"Pane","year":"1993","journal-title":"Clin. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review","volume":"329","author":"Shadman","year":"2023","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1182\/blood-2005-12-051458","article-title":"Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia","volume":"109","author":"Wierda","year":"2007","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10428199609054782","article-title":"Serum \u03b22-Microglobulin and Serum Thymidine Kinase are Independent Predictors of Progression-Free Survival in Chronic Lymphocytic Leukemia and Immunocytoma","volume":"22","author":"Hallek","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3109\/10428194.2015.1137291","article-title":"Evaluation of serum markers in the LRF CLL4 trial: \u03b22-microglobulin but not serum free light chains, is an independent marker of overall survival","volume":"57","author":"Pratt","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia: Presented in part at the 40th Annual Meeting of the American Society of Hematology, Miami Beach, FL, December 4\u20138 1998","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.7754\/Clin.Lab.2015.151125","article-title":"CD38 Expression and Variation as a Prognostic Factor Chronic Lymphocytic Leukemia","volume":"62","author":"Falay","year":"2016","journal-title":"Clin. Lab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cyto.b.20126","article-title":"Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia","volume":"70B","author":"Wiestner","year":"2006","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000491382","article-title":"Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?","volume":"140","author":"Rozovski","year":"2018","journal-title":"Acta Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/bjh.16042","article-title":"Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients","volume":"187","author":"Hu","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12288-018-1000-7","article-title":"Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia","volume":"35","author":"Farahat","year":"2019","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-015-0112-x","article-title":"Role of microRNA in chronic lymphocytic leukemia onset and progression","volume":"8","author":"Balatti","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia","volume":"353","author":"Ferracin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_58","unstructured":"Vakiti, A., and Mewawalla, P. (2024). Acute Myeloid Leukemia. StatPearls, StatPearls."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2005-05-2174","article-title":"Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype","volume":"106","author":"Boissel","year":"2005","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1200\/JCO.2004.06.060","article-title":"CEBPA Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations","volume":"22","author":"Schlenk","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.2011.01716.x","article-title":"Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia","volume":"88","author":"Soukup","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/modpathol.2014.160","article-title":"Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations","volume":"28","author":"Ohgami","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2009-11-250878","article-title":"Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: Prevalence and prognostic value","volume":"116","author":"Abbas","year":"2010","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/leu.2010.251","article-title":"Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients","volume":"25","author":"Nicolas","year":"2011","journal-title":"Leukemia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-5956-11-39","article-title":"Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling","volume":"11","author":"Bai","year":"2013","journal-title":"Proteome Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1002\/pmic.200400968","article-title":"Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia","volume":"4","author":"Cho","year":"2004","journal-title":"Proteomics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12032-013-0725-2","article-title":"Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation","volume":"30","author":"Luczak","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5306\/wjco.v12.i2.69","article-title":"Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review","volume":"12","author":"Sampaio","year":"2021","journal-title":"World J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13287-021-02155-6","article-title":"CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/10428194.2013.819100","article-title":"Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia","volume":"55","author":"Liu","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1097-0142(19820915)50:6<1122::AID-CNCR2820500616>3.0.CO;2-Q","article-title":"Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia","volume":"50","author":"Diamond","year":"1982","journal-title":"Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/sj.leu.2400847","article-title":"Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia","volume":"11","author":"Lacombe","year":"1997","journal-title":"Leukemia"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1309\/FY0UMAMM91VPMR2W","article-title":"Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry","volume":"129","author":"Gillis","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0043-1766137","article-title":"Flow Cytometric MRD Assessment in Acute Lymphoblastic Leukemias","volume":"44","author":"Virk","year":"2023","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1515\/folmed-2016-0004","article-title":"Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection","volume":"58","author":"Burnusuzov","year":"2016","journal-title":"Folia Med."},{"key":"ref_77","first-page":"6.38.31","article-title":"Method for DNA Ploidy Analysis along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet","volume":"80","author":"Tembhare","year":"2017","journal-title":"Curr. Protoc. Cytom."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"116377","DOI":"10.1016\/j.trac.2021.116377","article-title":"Rapid PCR powered by microfluidics: A quick review under the background of COVID-19 pandemic","volume":"143","author":"Dong","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s43586-023-00212-3","article-title":"Droplet-based microfluidics","volume":"3","author":"Moragues","year":"2023","journal-title":"Nat. Rev. Methods Primers"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/C3LC51152A","article-title":"The intersection of flow cytometry with microfluidics and microfabrication","volume":"14","author":"Piyasena","year":"2014","journal-title":"Lab Chip"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.22159\/ijap.2021v13i1.39032","article-title":"Microfluidic Devices as a Tool for Drug Delivery and Diagnosis: A Review","volume":"13","author":"Sharma","year":"2021","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/bit.27278","article-title":"A versatile oscillating-flow microfluidic PCR system utilizing a thermal gradient for nucleic acid analysis","volume":"117","author":"Kopparthy","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nphoton.2006.96","article-title":"Integrated optofluidics: A new river of light","volume":"1","author":"Monat","year":"2007","journal-title":"Nat. Photonics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/acssensors.3c02530","article-title":"A Microflow Cytometer Enabled by Monolithic Integration of a Microreflector with an Acoustic Resonator","volume":"9","author":"Wang","year":"2024","journal-title":"ACS Sens."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1\u2013risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"Westers","year":"2008","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2403680","article-title":"Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome","volume":"19","author":"Malcovati","year":"2005","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/ijmr.IJMR_924_18","article-title":"Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India","volume":"152","author":"Dhingra","year":"2020","journal-title":"Indian J. Med. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: A sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2016.147835","article-title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","volume":"102","author":"Westers","year":"2017","journal-title":"Haematologica"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1038\/s41598-017-05843-7","article-title":"High performance micro-flow cytometer based on optical fibres","volume":"7","author":"Etcheverry","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.proeng.2015.11.278","article-title":"Sheathless Separation of Particles and Cells by Viscoelastic Effects in Straight Rectangular Microchannels","volume":"126","author":"Liu","year":"2015","journal-title":"Procedia Eng."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"234501","DOI":"10.1103\/PhysRevLett.98.234501","article-title":"Tunable Nonlinear Viscoelastic \u201cFocusing\u2019\u2019 in a Microfluidic Device","volume":"98","author":"Leshansky","year":"2007","journal-title":"Phys. Rev. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1039\/c2lc21154h","article-title":"Single line particle focusing induced by viscoelasticity of the suspending liquid: Theory, experiments and simulations to design a micropipe flow-focuser","volume":"12","author":"Romeo","year":"2012","journal-title":"Lab Chip"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"108824","DOI":"10.1016\/j.celrep.2021.108824","article-title":"High-throughput multiparametric imaging flow cytometry: Toward diffraction-limited sub-cellular detection and monitoring of sub-cellular processes","volume":"34","author":"Holzner","year":"2021","journal-title":"Cell Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1002\/bit.27879","article-title":"A portable impedance microflow cytometer for measuring cellular response to hypoxia","volume":"118","author":"Dieujuste","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cyto.a.21083","article-title":"A microflow cytometer exploited for the immunological differentiation of leukocytes","volume":"79A","author":"Frankowski","year":"2011","journal-title":"Cytom. Part A"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Khalilian, P., Eskandari, N., Sharifi, M.J., Soltani, M., and Nematollahi, P. (2024). Toll-Like Receptor 4, 2, and Interleukin 1 Receptor Associated Kinase4: Possible Diagnostic Biomarkers in Myelodysplastic Syndrome Patients. Adv. Biomed. Res., 13.","DOI":"10.4103\/abr.abr_67_23"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/8\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:24:22Z","timestamp":1760109862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/8\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":98,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cimb46080476"],"URL":"https:\/\/doi.org\/10.3390\/cimb46080476","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}